Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.

Benson AB 3rd, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fakih MG, Fleshman JW Jr, Fuchs CS, Grem JL, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett C, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Apr;10(4):449-54.

PMID:
22491045
2.
3.

Positron emission tomography/computed tomography in the staging and treatment of anal cancer.

Sveistrup J, Loft A, Berthelsen AK, Henriksen BM, Nielsen MB, Engelholm SA.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):134-41. doi: 10.1016/j.ijrobp.2011.06.1955. Epub 2011 Oct 12.

PMID:
22000745
4.

Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.

Bannas P, Weber C, Adam G, Frenzel T, Derlin T, Mester J, Klutmann S.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):445-51. doi: 10.1016/j.ijrobp.2010.05.050. Epub 2010 Sep 9.

PMID:
20832181
5.

Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.

Mistrangelo M, Pelosi E, Bellò M, Castellano I, Cassoni P, Ricardi U, Munoz F, Racca P, Contu V, Beltramo G, Morino M, Mussa A.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):73-8. doi: 10.1016/j.ijrobp.2009.04.020. Epub 2009 Jul 23.

PMID:
19632066
6.

Assessing the impact of FDG-PET in the management of anal cancer.

Nguyen BT, Joon DL, Khoo V, Quong G, Chao M, Wada M, Joon ML, See A, Feigen M, Rykers K, Kai C, Zupan E, Scott A.

Radiother Oncol. 2008 Jun;87(3):376-82. doi: 10.1016/j.radonc.2008.04.003. Epub 2008 Apr 29.

PMID:
18453023
7.

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA; National Comprehensive Cancer Networks.

J Natl Compr Canc Netw. 2012 Jun 1;10(6):703-13.

8.

FDG-PET/CT: new horizons in anal cancer.

Grigsby PW.

Gastroenterol Clin Biol. 2009 May;33(5):456-8. doi: 10.1016/j.gcb.2009.01.012. Epub 2009 Apr 24.

9.

Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.

Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D'Amico AV, Eastham JA, Enke CA, Farrington T, Higano CS, Horwitz EM, Kantoff PW, Kawachi MH, Kuettel M, Lee RJ, MacVicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Roach M 3rd, Rohren E, Rosenfeld S, Srinivas S, Strope SA, Tward J, Twardowski P, Walsh PC, Ho M, Shead DA.

J Natl Compr Canc Netw. 2012 Sep;10(9):1081-7.

PMID:
22956807
10.

Assessment of target dose delivery in anal cancer using in vivo thermoluminescent dosimetry.

Weber DC, Nouet P, Kurtz JM, Allal AS.

Radiother Oncol. 2001 Apr;59(1):39-43.

PMID:
11295204
11.

Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.

Grabenbauer GG, Kessler H, Matzel KE, Sauer R, Hohenberger W, Schneider IH.

Dis Colon Rectum. 2005 Sep;48(9):1742-51.

PMID:
15991058
12.

Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.

Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Pène F, Parc R, Tiret E, Gallot D, Malafosse M, Laugier A.

Cancer. 1994 Mar 15;73(6):1569-79.

13.

PET-CT fusion in radiation management of patients with anorectal tumors.

Anderson C, Koshy M, Staley C, Esiashvili N, Ghavidel S, Fowler Z, Fox T, Esteves F, Landry J, Godette K.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):155-62.

PMID:
17707268
14.

Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review.

Piperkova E, Raphael B, Altinyay M, Castellon I, Libes R, Sandella N, Abdel-Dayem H.

J BUON. 2006 Oct-Dec;11(4):523-7.

PMID:
17309188
15.

Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?

Mai SK, Welzel G, Hermann B, Wenz F, Haberkorn U, Dinter DJ.

Strahlenther Onkol. 2009 Apr;185(4):254-9. doi: 10.1007/s00066-009-1944-5. Epub 2009 Apr 16.

PMID:
19370429
16.

Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.

Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):354-61.

PMID:
16168830
17.

PET/CT in anal cancer - is it worth doing?

Wells IT, Fox BM.

Clin Radiol. 2012 Jun;67(6):535-40. doi: 10.1016/j.crad.2011.10.030. Epub 2011 Dec 29.

PMID:
22208962
18.

Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma.

Iagaru A, Kundu R, Jadvar H, Nagle D.

Hell J Nucl Med. 2009 Jan-Apr;12(1):26-9.

PMID:
19330178
19.

FDG-PET/CT in the evaluation of anal carcinoma.

Cotter SE, Grigsby PW, Siegel BA, Dehdashti F, Malyapa RS, Fleshman JW, Birnbaum EH, Wang X, Abbey E, Tan B, Kodner IJ, Hunt SR, Lowney JK, Mutch MG, Dietz DW, Myerson RJ.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):720-5. Epub 2006 Apr 19.

PMID:
16626889
20.

Clinical practice guidelines for the utilization of positron emission tomography/computed tomography imaging in selected oncologic applications: suggestions from a provider group.

Manning K, Tepfer B, Goldklang G, Loyd R, Garimella P, Halkar R.

Mol Imaging Biol. 2007 Nov-Dec;9(6):324-32; discussion 323.

PMID:
17701257
Items per page

Supplemental Content

Write to the Help Desk